What is the recommended vaccination regimen for a patient over 50 to prevent shingles?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 2, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Shingrix (Recombinant Zoster Vaccine) Patient Education

What is Shingrix?

Shingrix is a highly effective, non-live vaccine that prevents shingles (herpes zoster) and its complications in adults aged 50 years and older, with over 97% effectiveness that remains above 83% for at least 8 years. 1, 2

  • Shingrix contains a single protein from the varicella zoster virus (not live virus) combined with a powerful adjuvant that boosts your immune response 2, 3
  • Unlike the older Zostavax vaccine, Shingrix maintains high effectiveness across all age groups and does not significantly decline with age 1, 3

Who Should Receive Shingrix?

Standard Recommendations

  • All adults aged 50 years and older should receive Shingrix, regardless of whether you've had shingles before or previously received Zostavax 1, 2
  • Adults aged 18-49 years who are immunocompromised due to disease or medications (such as cancer, HIV, organ transplant, or chronic immunosuppressive therapy) should also receive Shingrix 4, 2

You Should Get Vaccinated Even If:

  • You've already had shingles—having shingles once does not provide reliable protection against future episodes (10.3% recurrence risk over 10 years) 1
  • You previously received Zostavax—that vaccine's protection drops to only 14.1% by year 10, so you need Shingrix for adequate protection 1
  • You're on medications like prednisone, methotrexate, or biologics—Shingrix is safe and effective even with these medications 1, 4

Vaccination Schedule

Standard Two-Dose Series

  • First dose: Given at your initial visit 1, 2
  • Second dose: Given 2-6 months after the first dose 1, 2
  • Both doses are required for optimal protection—completing the full series is essential 1

Shortened Schedule for Immunocompromised Patients

  • If you are immunocompromised or about to start immunosuppressive therapy, the second dose can be given 1-2 months after the first dose 1, 2
  • Ideally, complete both doses before starting medications like JAK inhibitors (tofacitinib) or other strong immunosuppressants 1

Important Timing Notes

  • If you recently had shingles, wait at least 2 months after symptoms resolve before getting vaccinated 1
  • If you received Zostavax, wait at least 2 months before starting Shingrix 1
  • If the second dose is delayed beyond 6 months, you should still complete it—effectiveness is not impaired 1, 5

How Well Does Shingrix Work?

Effectiveness Against Shingles

  • 97.2% effective in preventing shingles in adults aged 50-69 years 1, 3
  • 89.8% effective in adults aged 70 years and older 1, 3
  • Real-world effectiveness: 70.1% for the complete two-dose series and 56.9% for one dose only 5

Effectiveness Against Postherpetic Neuralgia (PHN)

  • 88.8% effective in preventing the chronic nerve pain that can follow shingles in adults aged 70+ years 1
  • 76.0% effective against PHN in real-world studies 5

Duration of Protection

  • Protection remains above 83.3% for at least 8 years 1
  • No booster doses are currently recommended after completing the two-dose series 1

What to Expect: Side Effects

Very Common Side Effects (Most People Experience These)

Injection site reactions: 2

  • Pain at injection site (78% of people) 2
  • Redness (38%) and swelling (26%) 2

Systemic symptoms: 2

  • Muscle aches (45%) 2
  • Fatigue (45%) 2
  • Headache (38%) 2
  • Shivering (27%) 2
  • Fever (21%) 2
  • Gastrointestinal symptoms like nausea (17%) 2

Important Reassurance

  • Most side effects are mild to moderate and resolve within 2-4 days 1, 3
  • These reactions indicate your immune system is responding to the vaccine 3
  • Serious adverse events occur at similar rates to placebo 1, 3

Rare Serious Side Effects

  • Guillain-Barré syndrome: An increased risk was observed in the 42 days following vaccination, though this remains very rare 2
  • Severe allergic reactions: Extremely rare but possible—do not receive Shingrix if you had a severe allergic reaction to any component or a previous dose 2

Managing Side Effects

  • Take over-the-counter pain relievers (acetaminophen or ibuprofen) as needed 1
  • Apply a cool compress to the injection site 1
  • Rest if you feel fatigued 1
  • Stay hydrated 1

Special Situations

If You're on Immunosuppressive Medications

  • Shingrix is safe for patients on glucocorticoids, DMARDs, biologics, and other immunosuppressants 1, 4
  • The vaccine may cause mild disease flares (4-17%) in patients with autoimmune conditions, but no serious adverse events 1
  • Your immune response may be somewhat reduced compared to healthy individuals, but vaccination still provides meaningful protection 1, 5

If You're Starting JAK Inhibitors (like tofacitinib)

  • Ideally, complete both Shingrix doses before starting the medication to maximize immune response 1
  • If urgent treatment is needed, get at least the first dose before starting, then complete the second dose 1-2 months later 1
  • Never receive the live Zostavax vaccine if you're on or about to start these medications 1

If You Have Cancer or Are Receiving Chemotherapy

  • Shingrix is the only appropriate shingles vaccine for immunocompromised patients—Zostavax is contraindicated 1, 4
  • For stem cell transplant recipients, give Shingrix 50-70 days post-transplantation 1
  • Consider timing doses between chemotherapy cycles when feasible (>7 days after last treatment) 1

If You're on Low-Dose Steroids

  • Prednisone <10 mg/day does not adversely impact vaccine response 1
  • You can safely receive Shingrix without adjusting your steroid dose 1

Why Shingrix is Superior to Zostavax

  • Much higher effectiveness: Shingrix 97% vs. Zostavax 46-70% initially, declining to 14.1% by year 10 1, 3
  • Maintains effectiveness with age: Zostavax drops from 70% in ages 50-59 to only 18% in those ≥80 years 1
  • Longer-lasting protection: Shingrix remains >83% effective for at least 8 years 1
  • Safe for immunocompromised patients: Shingrix can be given to immunocompromised individuals, while Zostavax cannot 1, 4

Common Questions

Can I get shingles from the vaccine?

  • No. Shingrix contains only a protein fragment, not live virus, so it cannot cause shingles under any circumstances 1, 2

Do I need a booster after the two doses?

  • No. No additional booster doses are currently recommended beyond the initial two-dose series 1

Can I get Shingrix with other vaccines?

  • Yes. Shingrix can be given at the same time as flu vaccine or other inactivated vaccines 1
  • Wait until acute illness symptoms (fever, severe malaise) have resolved before vaccination 1

What if I'm under 50 but had shingles?

  • Having had shingles does not justify earlier vaccination unless you are immunocompromised 1
  • The vaccine is only approved for adults ≥50 years (or ≥18 years if immunocompromised) 4, 2

Can I get vaccinated if I'm pregnant?

  • Shingrix has not been studied in pregnant women—discuss with your healthcare provider 2

What Shingrix Does NOT Do

  • Does not treat active shingles—if you have shingles now, you need antiviral medication like valacyclovir 6
  • Does not prevent chickenpox—if you've never had chickenpox or the chickenpox vaccine, you need varicella vaccine, not Shingrix 1, 2
  • Does not eliminate all risk—about 8 out of 100 vaccinated people might still develop shingles, but usually with milder symptoms 1, 5

Bottom Line

Shingrix is the most effective vaccine available to prevent shingles and its complications, with over 97% effectiveness that lasts for at least 8 years. 1, 3 While side effects like injection site pain and fatigue are common, they are temporary and mild to moderate in severity. 2, 3 Completing both doses 2-6 months apart is essential for optimal protection. 1, 2

References

Guideline

SHINGRIX Vaccination Schedule for Adults

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Special Indications for Shingrix Under Age 50

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Recombinant Zoster Vaccine (Shingrix): Real-World Effectiveness in the First 2 Years Post-Licensure.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2021

Guideline

Management of Herpes Zoster

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.